Covaxin phase 3 data shows 77.8% efficacy: Lancet{br} https://ift.tt/eA8V8J

A week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, a prestigious medical journal Lancet has stated that the phase 3 data of India’s first indigenously developed vaccine demonstrates 77.8% efficacy against symptomatic Covid-19. Its efficacy data also demonstrates 70.8% protection against all variants of SARS-CoV-2.

from Times of India https://ift.tt/30aDSMa

Comments

Post a Comment

Popular posts from this blog

'A hard goodbye with...': Pathirana to CSK and Dhoni{br} https://ift.tt/vpqjikg

Chennai Super Kings' pacer Matheesha Pathirana's participation in the current IPL season seems to be over as he returns to Sri Lanka to recuperate from a hamstring injury. The right-arm fast bowler appeared in six matches this IPL season, claiming 13 wickets with an economy rate of 7.68. Pathirana's final game for CSK was their 78-run win against Sunrisers Hyderabad, where he bowled two overs and took the wickets of Aiden Markram and Heinrich Klaasen. from Times of India https://ift.tt/YwB9gnD
Read more